Callitas Health Inc

(MPHMF)

By |

Profile

Callitas Health Inc is a clinical-stage company. It is engaged in developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications. The company's products offering includes ToConceive, C-103 Reformulated Orlistat, and Extrinsa. ToConceive is a fertility enhancing moisturizer. It is clinically proven to increase a woman's own natural conception lubrication, called transudate, to aid in conception. Orlistat is FDA-approved for weight management and sold by Roche as Xenical (prescription) and by GlaxoSmithKline as alli. Extrinsa focuses on women with orgasm and arousal difficulties. The topical, local, and the non-systemic product is also non-hormonal and does not affect the central nervous system.

Contact Information

Website: www.callitas.com
Main Phone: +1 859 868-3131
Address: 187 Pavilion Parkway
Address 2: Suite 200
State: KY
City / Town: Newport
Country: USA
Postal Code: 41071

Issuer Information

Exchange: OTCQB
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.069 $ 0. (0.00%)
Last Price 0.069 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.069
Last Trade Volume 0 52 Wk Hi 0.28 52 Wk Low 0.0686
Market Cap 2.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 32,880,095.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCQB
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4.1 4.1 4.1 4.1
Low Target Price Estimate 4.1 4.1 4.1 4.1
Mean Target Price Estimate 4.1 4.1 4.1 4.1
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 02/16/17 02/16/17 02/16/17 02/16/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago